Cart
Compound Libraries Approved / Repurposing

Approved / Repurposing

There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.

Cat No. product name
L4200 FDA-approved Drug Library A unique collection of 1470 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); 1470 compounds
L9200 Drug Repurposing Library A unique collection of 3512 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); 3512 compounds
L1010 FDA Approved & Pharmacopeial Drug Library 2978 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); 2978 compounds
L1000 Approved Drug Library A unique collection of 2356 approved drugs for high throughput screening (HTS) and high content screening (HCS); 2356 compounds
L3410 Preclinical Compound Library A unique collection of 619 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); 619 compounds
L3400 Clinical Compound Library A unique collection of 2500 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); 2500 compounds
FDA-approved Drug Library
L4200 compounds - 1470
Drug Repurposing Library
L9200 compounds - 3512
FDA Approved & Pharmacopeial Drug Library
L1010 compounds - 2978
Approved Drug Library
L1000 compounds - 2356
Preclinical Compound Library
L3410 compounds - 619
Clinical Compound Library
L3400 compounds - 2500